Pacira Biosciences
PCRX
#6309
Rank
ยฃ0.74 B
Marketcap
ยฃ19.04
Share price
0.80%
Change (1 day)
2.97%
Change (1 year)
Categories

Earnings for Pacira Biosciences (PCRX)

Earnings in 2026 (TTM): ยฃ13.21 Million

According to Pacira Biosciences 's latest financial reports the company's current earnings are ยฃ0.74 Billion. In 2025 the company made an earning of ยฃ12.74 Million, an increase over its 2024 earnings that were of -ยฃ47.67 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Pacira Biosciences from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ13.21 M3.66%
2025 ยฃ12.74 M-126.74%
2024 -ยฃ47.67 Million-202.28%
2023 ยฃ46.6 M363.85%
2022 ยฃ10.04 M-76.42%
2021 ยฃ42.6 M180.76%
2020 ยฃ15.17 M-286.92%
2019 -ยฃ8.12 Million2428.94%
2018 -ยฃ0.33 Million-99%
2017 -ยฃ32.08 Million12.23%
2016 -ยฃ28.59 Million-1885.05%
2015 ยฃ1.6 M-115.65%
2014 -ยฃ10.23 Million-78.95%
2013 -ยฃ48.61 Million21.55%
2012 -ยฃ39.99 Million41.18%
2011 -ยฃ28.33 Million57.4%
2010 -ยฃ18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Zogenix
ZGNX
-ยฃ0.17 Billion-1,301.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
ยฃ2.84 M-78.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
ยฃ12.06 M-9.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-ยฃ59.96 Million-549.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
-ยฃ25.72 Million-292.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-ยฃ47.43 Million-455.80%๐Ÿ‡บ๐Ÿ‡ธ USA